Dermata Therapeutics up to $12.4 M Private Placement Priced At-The-Market

Dermata Therapeutics (NASDAQ:DRMA / DRMAW) announced a private placement to issue 2,022,062 shares (or pre-funded warrants) plus series C and short-term series D warrants at $2.04 per share, providing approximately $4.1 million of gross proceeds upfront and up to ~$8.3 million additional if warrants are fully exercised (total ~$12.4 million). Series C warrants expire five years; series D warrants expire 24 months; warrant exercises and amended warrants are subject to stockholder approval. Closing expected on or about December 29, 2025.

https://www.stocktitan.net/news/DRMA/dermata-therapeutics-announces-up-to-12-4-million-private-placement-9ix6rwb46ezy.html